|
Jun 25
|
Sector Update: Health Care Stocks Advance Late Afternoon
|
|
Jun 25
|
Top Midday Gainers
|
|
Jun 25
|
Sector Update: Health Care Stocks Softer Wednesday Afternoon
|
|
Jun 25
|
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
|
|
Jun 4
|
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
|
|
Apr 3
|
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
|
|
Mar 31
|
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
|
|
Mar 19
|
Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes
|
|
Sep 3
|
JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS
|
|
Aug 27
|
GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS
|
|
Jun 13
|
GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR
|
|
Jan 10
|
Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream
|
|
Nov 30
|
GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
|